- Home
- ATRA vs GCV Comparison
ATRA vs GCV Comparison
Compare ATRA & GCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- GCV
- Stock Information
- Founded
- ATRA 2012
- GCV 1988
- Country
- ATRA United States
- GCV United States
- Employees
- ATRA N/A
- GCV N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- GCV Finance/Investors Services
- Sector
- ATRA Health Care
- GCV Finance
- Exchange
- ATRA Nasdaq
- GCV Nasdaq
- Market Cap
- ATRA 97.0M
- GCV 85.1M
- IPO Year
- ATRA 2014
- GCV N/A
- Fundamental
- Price
- ATRA $13.04
- GCV $4.10
- Analyst Decision
- ATRA Strong Buy
- GCV
- Analyst Count
- ATRA 3
- GCV 0
- Target Price
- ATRA $21.00
- GCV N/A
- AVG Volume (30 Days)
- ATRA 59.0K
- GCV 57.9K
- Earning Date
- ATRA 11-12-2025
- GCV 01-01-0001
- Dividend Yield
- ATRA N/A
- GCV 13.04%
- EPS Growth
- ATRA N/A
- GCV N/A
- EPS
- ATRA 1.97
- GCV N/A
- Revenue
- ATRA $151,930,000.00
- GCV N/A
- Revenue This Year
- ATRA N/A
- GCV N/A
- Revenue Next Year
- ATRA N/A
- GCV N/A
- P/E Ratio
- ATRA $6.70
- GCV N/A
- Revenue Growth
- ATRA 51.27
- GCV N/A
- 52 Week Low
- ATRA $5.01
- GCV $3.15
- 52 Week High
- ATRA $18.71
- GCV $4.58
- Technical
- Relative Strength Index (RSI)
- ATRA 47.86
- GCV 31.15
- Support Level
- ATRA $11.21
- GCV $4.22
- Resistance Level
- ATRA $14.28
- GCV $4.30
- Average True Range (ATR)
- ATRA 1.33
- GCV 0.08
- MACD
- ATRA 0.01
- GCV -0.03
- Stochastic Oscillator
- ATRA 52.74
- GCV 8.82
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.